integrated sensors

Patient Selection: Ensure participants or caregivers are trained and capable of storing/administering IMP correctly

Vendor performance should align with your validation master plan and be documented in the trial file.

Shipping Considerations for IMP to Home Settings:

Ensure all shipments comply with regulatory standards:

• Courier SOPs: Must cover pickup, transit, delivery, and confirmation
• Temperature Monitoring: Use data loggers and alert systems to detect excursions
• Chain of Custody: Signature required from authorized recipient (patient or nurse)
• Tamper Evidence: Seal labels with photographic verification options
• Backup Shipments: Maintain contingency stock at local hubs for time-sensitive therapies

Shipments must also comply with GMP documentation protocols and have preapproved labels.

IMP Storage at Patient’s Home:

Storage considerations are critical for maintaining product integrity:

• Pre-screen patients for access to refrigeration (if required)
• Provide insulated storage boxes with digital thermometers
• Supply storage instructions in patient’s preferred language
• Require patient or caregiver acknowledgment of daily temperature logs
• Use smart packaging with integrated sensors where budget permits

Storage verification should be included in the SOP checklist for nurse visits.

Home-Based Dosing Administration Protocols:

Home administration may be done by the patient, caregiver, or a trained home nurse:

• Oral Dosing: Confirm time and quantity using patient logs and photo documentation
• Injectables: Require trained nursing administration and adverse event documentation
• Infusions: May require emergency backup or physician oversight for complex regimens
• Missed Doses: Define protocol for missed or delayed doses in visit plans
• Adverse Events: Escalate and report any reactions within 24 hours

Ensure all nurses are trained in stability indicating methods and product-specific precautions.

Documentation and IMP Accountability:

Accurate documentation is a regulatory requirement and protects data integrity:

1. Dispensing Logs: Record IMP ID, lot number, expiry, and quantity shipped/administered
2. Return Logs: Unused medication should be returned or destroyed per protocol
3. Temperature Records: Should be available for each shipment and stored in eTMF
4. Drug Reconciliation: Conduct periodic reconciliation of shipped vs. used IMP
5. Deviation Tracking: Log any errors in administration, delivery delays, or temperature excursions

Risk Mitigation Strategies:

• Establish multiple shipping vendors to avoid single point failures
• Use predictive tracking tools to anticipate delays
• Define escalation pathways for delivery failures or missed doses
• Ensure insurance or liability protection for high-value medications
• Maintain batch-level recall plans even for direct-to-patient shipments

Incorporate all risk plans into the broader pharma regulatory compliance framework of your organization.

Best Practices for Training and Oversight:

Train all stakeholders to maintain consistency and quality:

• Study nurses must be trained in IMP handling and patient instruction
• Patients and caregivers need dosing diaries and storage guidance
• Clinical monitors should include supply chain audits during site evaluations
• PI oversight remains mandatory for all home-based dosing decisions

These training modules should be documented under SOP training pharma logs for inspections.

Conclusion:

Home-based dosing in DCTs introduces a complex supply chain that blends logistics, quality control, regulatory compliance, and patient-centric innovation. By adopting best practices—such as cold chain validation, secure delivery, clear documentation, and robust training—sponsors can ensure that investigational products reach patients safely and effectively, supporting both protocol integrity and participant convenience. An efficient and validated supply chain is the backbone of successful decentralized dosing operations.